Results 51 to 60 of about 5,511 (190)

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?

open access: yesToxins, 2020
Gut microbial metabolism is not only an important source of uremic toxins but may also help to maintain the vitamin K stores of the host. We hypothesized that sevelamer therapy, a commonly used phosphate binder in patients with end-stage kidney disease ...
Lu Dai   +7 more
doaj   +1 more source

Biomehanička svojstva kostiju štakora tretiranih sevelamerom [PDF]

open access: yes, 2011
Sevelamer hydrochloride is used for ten years in patients on dialysis as a phosphate binder. We have previously shown that oral application of sevelamer prevents the bone loss and increases the bone volume in ovariectomized rats. In this study we further
Brnčić, Mladen   +5 more
core  

Lanthanum associated abnormal liver function tests in two patients on dialysis: a case report [PDF]

open access: yes, 2009
Lanthanum (La) is a phosphate binder used in patients on dialysis in the UK. As it has only recently been in use, there are no long-term data about safety of this rare metal in human subjects with renal failure on renal replacement therapy.
Daryanani Indiver   +8 more
core   +2 more sources

Osteitis Fibrosa Cystica: An Unusual Cause of Left‐Sided Chest Pain

open access: yesCase Reports in Nephrology, Volume 2026, Issue 1, 2026.
We report a case of osteitis fibrosa cystica resulting from secondary hyperparathyroidism in a 21‐year‐old male patient with end‐stage renal disease. The patient presented with persistent, moderate chest pain localized to the left fifth and sixth ribs for eight months. A chest X‐ray revealed well‐defined, expansile lytic lesions in these ribs.
Raahima Habib   +4 more
wiley   +1 more source

Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA.

open access: yesPLoS ONE, 2017
BackgroundChronic kidney disease-mineral and bone disorder (CKD-MBD), a complication of chronic kidney disease, has been linked to reduced quality and length of life. High serum phosphate levels that result from CKD-MBD require phosphate-lowering agents,
Nigar Sekercioglu   +7 more
doaj   +1 more source

Deleting death and dialysis: Conservative care of cardio-vascular risk and kidney function loss in chronic kidney disease (CKD) [PDF]

open access: yes, 2018
The uremic syndrome, which is the clinical expression of chronic kidney disease (CKD), is a complex amalgam of accelerated aging and organ dysfunctions, whereby cardio-vascular disease plays a capital role. In this narrative review, we offer a summary of
Castillo-Rodriguez, Esmeralda   +5 more
core   +4 more sources

Calciphylaxis Post‐Renal Transplantation: Two Cases and a Literature Review

open access: yesOrgan Medicine, Volume 2, Issue 4, Page 153-159, December 2025.
Calciphylaxis post‐renal transplant is a life‐threatening vasculopathy with high mortality. We report two cases managed successfully via early histopathological diagnosis and intravenous sodium thiosulfate therapy. Early diagnosis and intervention, along with renal function recovery, positively impact prognosis, highlighting the clinical relevance of ...
Luhao Liu   +8 more
wiley   +1 more source

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis

open access: yesTherapeutics and Clinical Risk Management, 2008
Vincenzo Savica1,2, Domenico Santoro1, Paolo Monardo2, Agostino Mallamace1, Guido Bellinghieri11Experimental and Clinic Department of Internal Medicine and Pharmacology, University of Messina, Italy; 2Nephrology and Dialysis Unit, Papardo Hospital ...
Vincenzo Savica   +4 more
doaj  

A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2014
In the present study, a comparative evaluation of the effects of calcium acetate, calcium carbonate, sevelamer hydrochloride and lanthanum carbonate was carried out in 120 patients with end stage kidney disease (ESKD) undergoing hemodialysis. Biochemical
Viken A Prajapati   +2 more
doaj   +1 more source

Single Center, Open‐Label, Randomized Crossover Trial on Drug–Drug Interactions of Levothyroxine/Magnesium‐Citrate and Levothyroxine/Magnesium‐Aspartate in Healthy Subjects—The ThyroMag Trial

open access: yesClinical and Translational Science, Volume 18, Issue 11, November 2025.
ABSTRACT Divalent cations such as calcium and ferrous sulfate interfere with the absorption of levothyroxine due to complexing. To our knowledge, the effects of magnesium on levothyroxine absorption have never been studied. The open‐label cross‐over pharmacokinetic study was conducted in 15 healthy, euthyroid adults.
Martin Christian Attinger   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy